Condensed Statements of Operations - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2021	Mar. 31, 2020
Operating expenses:
Research and development	$ 1,979	$ 2,115
General and administrative	1,918	540
Total operating expenses	3,897	2,655
Loss from operations	(3,897)	(2,655)
Interest expense, net	(1)	(22)
Net loss	$ (3,898)	$ (2,677)
Per share information:
Net loss per share of common stock, basic and diluted	$ (0.37)	$ (2.44)
Weighted-average common shares outstanding, basic and diluted	10,640,870	1,099,270